In the palm of your hand, it looks like a glop of hair gel. But this goo could one day revolutionize the reproductive health landscape by being the first male birth control to hit the market.
On Sunday, we got one step closer to that reality. Scientists with the National Institutes of Health’s Contraceptive Development Program announced encouraging results from a phase 2 trial demonstrating the safety and efficacy of the drug.
